These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 8393163

  • 1. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E, Boldyreff B, Scheidtmann KH.
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cells.
    Deppert W, Kurth M, Graessmann M, Graessmann A, Knippschild U.
    Oncogene; 1991 Oct; 6(10):1931-8. PubMed ID: 1923516
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme.
    Milne DM, Palmer RH, Campbell DG, Meek DW.
    Oncogene; 1992 Jul; 7(7):1361-9. PubMed ID: 1620549
    [Abstract] [Full Text] [Related]

  • 9. DNA-damage-inducible p53 activity in SV40-transformed cells.
    Hess RD, Brandner G.
    Oncogene; 1997 Nov 13; 15(20):2501-4. PubMed ID: 9395246
    [Abstract] [Full Text] [Related]

  • 10. Disruption of LT-antigen/p53 complex by heat treatment correlates with inhibition of DNA synthesis during transforming infection with SV40.
    Khandjian EW, Rose TM.
    Biochem Cell Biol; 2000 Nov 13; 78(4):437-45. PubMed ID: 11012082
    [Abstract] [Full Text] [Related]

  • 11. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
    Hu MC, Qiu WR, Wang YP.
    Oncogene; 1997 Nov 06; 15(19):2277-87. PubMed ID: 9393873
    [Abstract] [Full Text] [Related]

  • 12. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53.
    Salewski H, Bayer TA, Eidhoff U, Preuss U, Weggen S, Scheidtmann KH.
    Cancer Res; 1999 Apr 15; 59(8):1980-6. PubMed ID: 10213510
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.
    Reihsaus E, Kohler M, Kraiss S, Oren M, Montenarh M.
    Oncogene; 1990 Jan 15; 5(1):137-45. PubMed ID: 2157179
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of SV40 large T antigen induced apoptosis by small T antigen.
    Kolzau T, Hansen RS, Zahra D, Reddel RR, Braithwaite AW.
    Oncogene; 1999 Sep 30; 18(40):5598-603. PubMed ID: 10523837
    [Abstract] [Full Text] [Related]

  • 15. Polyomavirus large T antigen overcomes p53 dependent growth arrest.
    Doherty J, Freund R.
    Oncogene; 1997 Apr 24; 14(16):1923-31. PubMed ID: 9150359
    [Abstract] [Full Text] [Related]

  • 16. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.
    Dkhissi F, Raynal S, Jullien P, Lawrence DA.
    Oncogene; 1999 Jan 21; 18(3):703-11. PubMed ID: 9989820
    [Abstract] [Full Text] [Related]

  • 17. Mouse p53 inhibits SV40 origin-dependent DNA replication.
    Braithwaite AW, Sturzbecher HW, Addison C, Palmer C, Rudge K, Jenkins JR.
    Nature; 1999 Jan 21; 329(6138):458-60. PubMed ID: 2821401
    [Abstract] [Full Text] [Related]

  • 18. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F, Deppert W.
    Oncogene; 1994 Jul 21; 9(7):1907-15. PubMed ID: 8208537
    [Abstract] [Full Text] [Related]

  • 19. Association of casein kinase II with immunopurified p53.
    Herrmann CP, Kraiss S, Montenarh M.
    Oncogene; 1991 May 21; 6(5):877-84. PubMed ID: 2052362
    [Abstract] [Full Text] [Related]

  • 20. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.
    Tavis JE, Trowbridge PW, Frisque RJ.
    Virology; 1994 Mar 21; 199(2):384-92. PubMed ID: 8122368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.